Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 9043
Country/Region: Uganda
Year: 2016
Main Partner: Henry M. Jackson Foundation for the Advancement of Military Medicine
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USDOD
Total Funding: $8,193,639 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,363,410
Care: Orphans and Vulnerable Children (HKID) $734,675
Care: TB/HIV (HVTB) $1,145,716
Care: Pediatric Care and Support (PDCS) $385,564
Laboratory Infrastructure (HLAB) $60,624
Strategic Information (HVSI) $260,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $739,476
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Prevention: HIV Testing and Counseling (HVCT) $413,948
Sexual Prevention: Other Sexual Prevention (HVOP) $503,031
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $349,271
Treatment: Adult Treatment (HTXS) $2,121,941
Treatment: Pediatric Treatment (PDTX) $115,983
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD Age/Sex: 10-14 Female 2017 441
GEND_GBV_DSD Age/Sex: 10-14 Male 2017 95
GEND_GBV_DSD Age/Sex: 15-19 Female 2017 798
GEND_GBV_DSD Age/Sex: 15-19 male 2017 154
GEND_GBV_DSD Age/Sex: 20-24 Female 2017 780
GEND_GBV_DSD Age/Sex: 20-24 Male 2017 160
GEND_GBV_DSD Age/Sex: 25-49 Female 2017 321
GEND_GBV_DSD Age/Sex: 25-49 Male 2017 160
GEND_GBV_DSD Age/Sex: <10 Female 2017 160
GEND_GBV_DSD Age/Sex: <10 Male 2017 95
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2017 286
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 698
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2017 2,466
GEND_GBV_DSD Number of people receiving post-GBV care 2017 3,164
GEND_GBV_DSD Sum of Age/Sex Disaggregates 2017 791
GEND_GBV_TA Age/Sex: 10-14 Female 2017 76
GEND_GBV_TA Age/Sex: 10-14 Male 2017 13
GEND_GBV_TA Age/Sex: 15-19 Female 2017 132
GEND_GBV_TA Age/Sex: 15-19 Male 2017 22
GEND_GBV_TA Age/Sex: 20-24 Female 2017 146
GEND_GBV_TA Age/Sex: 20-24 Male 2017 26
GEND_GBV_TA Age/Sex: 25-49 Female 2017 54
GEND_GBV_TA Age/Sex: 25-49 Male 2017 26
GEND_GBV_TA Age/Sex: <10 Female 2017 26
GEND_GBV_TA Age/Sex: <10 Male 2017 13
GEND_GBV_TA By PEP service provision (related to sexual violence services provided) 2017 46
GEND_GBV_TA By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 118
GEND_GBV_TA By type of service: Sexual Violence (Post-Rape Care) 2017 416
GEND_GBV_TA Number of people receiving post-GBV care 2017 534
GEND_GBV_TA Sum of Age/Sex Disaggregates 2017 128
HTC_TST_DSD Age/sex: 1-9 2017 4,103
HTC_TST_DSD Age/sex: 10-14 Female 2017 3,528
HTC_TST_DSD Age/sex: 10-14 Male 2017 3,533
HTC_TST_DSD Age/sex: 15-19 Female 2017 21,711
HTC_TST_DSD Age/sex: 15-19 Male 2017 26,579
HTC_TST_DSD Age/sex: 20-24 Female 2017 32,566
HTC_TST_DSD Age/sex: 20-24 Male 2017 39,869
HTC_TST_DSD Age/sex: 25-49 Female 2017 49,931
HTC_TST_DSD Age/sex: 25-49 Male 2017 61,132
HTC_TST_DSD Age/sex: 50+ Female 2017 4,337
HTC_TST_DSD Age/sex: 50+ Male 2017 5,313
HTC_TST_DSD Age/sex: <1 2017 1,253
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 108,545
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 132,893
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 6,203
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 6,214
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 253,855
HTC_TST_DSD Service Delivery Point (Facility): Index testing 2017 12,869
HTC_TST_DSD Service Delivery Point (Facility): Inpatient 2017 26,989
HTC_TST_DSD Service Delivery Point (Facility): Other PITC 2017 14,266
HTC_TST_DSD Service Delivery Point (Facility): Outpatient 2017 79,547
HTC_TST_DSD Service Delivery Point (Facility): Pediatric 2017 9,470
HTC_TST_DSD Service Delivery Point (Facility): PMTCT 2017 50,243
HTC_TST_DSD Service Delivery Point (Facility): TB Clinics 2017 1,245
HTC_TST_DSD Service Delivery Point (Facility): VMMC 2017 59,226
HTC_TST_DSD Sum of Age/Sex disaggregates 2017 248,499
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2017 241,438
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2017 12,417
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2017 253,855
HTC_TST_DSD Test Result by Age and Sex: Positive: 10-14 Female 2017 164
HTC_TST_DSD Test Result by Age and Sex: Positive: 10-14 Male 2017 165
HTC_TST_DSD Test Result by Age and Sex: Positive: 15-19 Female 2017 957
HTC_TST_DSD Test Result by Age and Sex: Positive: 15-19 Male 2017 584
HTC_TST_DSD Test Result by Age and Sex: Positive: 20-24 Female 2017 1,443
HTC_TST_DSD Test Result by Age and Sex: Positive: 20-24 Male 2017 877
HTC_TST_DSD Test Result by Age and Sex: Positive: 25-49 Female 2017 2,208
HTC_TST_DSD Test Result by Age and Sex: Positive: 25-49 Male 2017 1,338
HTC_TST_DSD Test Result by Age and Sex: Positive: 50+ Female 2017 187
HTC_TST_DSD Test Result by Age and Sex: Positive: 50+ Male 2017 112
HTC_TST_DSD Test Result by Age: Positive: 1-9 2017 184
HTC_TST_DSD Test Result by Age: Positive: <1 2017 47
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,795
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,911
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Female 2017 277
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Male 2017 283
HTC_TST_TA Age/sex: 1-9 2017 670
HTC_TST_TA Age/sex: 10-14 Female 2017 573
HTC_TST_TA Age/sex: 10-14 Male 2017 573
HTC_TST_TA Age/sex: 15-19 Female 2017 3,308
HTC_TST_TA Age/sex: 15-19 Male 2017 2,181
HTC_TST_TA Age/sex: 20-24 Female 2017 4,963
HTC_TST_TA Age/sex: 20-24 Male 2017 3,278
HTC_TST_TA Age/sex: 25-49 Female 2017 7,610
HTC_TST_TA Age/sex: 25-49 Male 2017 5,023
HTC_TST_TA Age/sex: 50+ Female 2017 660
HTC_TST_TA Age/sex: 50+ Male 2017 431
HTC_TST_TA Age/sex: <1 2017 205
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 16,541
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 10,913
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,015
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,006
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 29,475
HTC_TST_TA Service Delivery Point (Facility): Index testing 2017 1,804
HTC_TST_TA Service Delivery Point (Facility): Inpatient 2017 3,715
HTC_TST_TA Service Delivery Point (Facility): Other PITC 2017 1,831
HTC_TST_TA Service Delivery Point (Facility): Outpatient 2017 9,734
HTC_TST_TA Service Delivery Point (Facility): Pediatric 2017 1,471
HTC_TST_TA Service Delivery Point (Facility): PMTCT 2017 9,254
HTC_TST_TA Service Delivery Point (Facility): TB Clinics 2017 168
HTC_TST_TA Service Delivery Point (Facility): VMMC 2017 1,498
HTC_TST_TA Sum of Age/Sex disaggregates 2017 28,600
HTC_TST_TA Sum of Aggregated Age/Sex 15+ 2017 27,454
HTC_TST_TA Sum of Aggregated Age/Sex <15 2017 2,021
HTC_TST_TA Sum of Aggregated Age/Sex disaggregates 2017 29,475
HTC_TST_TA Test Result by Age and Sex: Positive: 10-14 Female 2017 32
HTC_TST_TA Test Result by Age and Sex: Positive: 10-14 Male 2017 25
HTC_TST_TA Test Result by Age and Sex: Positive: 15-19 Female 2017 151
HTC_TST_TA Test Result by Age and Sex: Positive: 15-19 Male 2017 64
HTC_TST_TA Test Result by Age and Sex: Positive: 20-24 Female 2017 228
HTC_TST_TA Test Result by Age and Sex: Positive: 20-24 Male 2017 103
HTC_TST_TA Test Result by Age and Sex: Positive: 25-49 Female 2017 348
HTC_TST_TA Test Result by Age and Sex: Positive: 25-49 Male 2017 156
HTC_TST_TA Test Result by Age and Sex: Positive: 50+ Female 2017 29
HTC_TST_TA Test Result by Age and Sex: Positive: 50+ Male 2017 20
HTC_TST_TA Test Result by Age: Positive: 1-9 2017 22
HTC_TST_TA Test Result by Age: Positive: <1 2017 5
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 756
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 343
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive <15 Female 2017 45
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive <15 Male 2017 39
KP_PREV_DSD By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 9,466
KP_PREV_DSD By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 6,215
KP_PREV_DSD Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 6,215
KP_PREV_DSD Total estimated number of key population in the catchment area 2017 9,466
LAB_PT_DSD TB diagnostics (Xpert MTB/RIF): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 105
LAB_PT_DSD TB diagnostics (Xpert MTB/RIF): Number of laboratories that participate in this PT program 2017 105
LAB_PT_DSD TB diagnostics (Xpert MTB/RIF): Number of laboratories that perform this testing 2017 105
OVC_SERV_DSD Age/Sex: 18+ Female 2017 1,401
OVC_SERV_DSD Age/Sex: 18+ Male 2017 1,159
OVC_SERV_DSD By Aggregated Age/Sex: <18 Female 2017 3,999
OVC_SERV_DSD By Aggregated Age/Sex: <18 Male 2017 3,740
OVC_SERV_DSD Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 14,364
OVC_SERV_DSD Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2017 1,219
OVC_SERV_DSD Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2017 813
OVC_SERV_DSD Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2017 2,033
OVC_SERV_DSD Sum of Age/Sex disaggregates 2017 2,560
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2017 2,077
PMTCT_ART_DSD New on ART 2017 1,492
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 50,423
PMTCT_ART_TA Already on ART at beginning of current pregnancy 2017 392
PMTCT_ART_TA New on ART 2017 279
PMTCT_ART_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,284
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2017 2,358
PMTCT_EID_DSD By infants who received their first virologic HIV test between 2 and 12 months of age 2017 651
PMTCT_EID_DSD Number of infants with a positive virological test result within 12 months of birth 2017 25
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2017 120
PMTCT_EID_DSD Sum of Infant Age disaggregates 2017 3,009
PMTCT_EID_TA By infants who received a virologic test within 2 months of birth 2017 439
PMTCT_EID_TA By infants who received their first virologic HIV test between 2 and 12 months of age 2017 121
PMTCT_EID_TA Number of infants with a positive virological test result within 12 months of birth 2017 1
PMTCT_EID_TA Number of infants with a positive virological test result within 2 months of birth 2017 18
PMTCT_EID_TA Sum of Infant Age disaggregates 2017 560
PMTCT_STAT_DSD By: Known positives at entry 2017 2,113
PMTCT_STAT_DSD By: Number of new positives identified 2017 1,647
PMTCT_STAT_DSD Number of new ANC and L&D clients 2017 51,712
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 50,423
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2017 3,760
PMTCT_STAT_TA By: Known positives at entry 2017 380
PMTCT_STAT_TA By: Number of new positives identified 2017 318
PMTCT_STAT_TA Number of new ANC and L&D clients 2017 9,526
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,284
PMTCT_STAT_TA Sum of Positives Status disaggregates 2017 698
PP_PREV_DSD Aggregated Age/sex: 15+ Female 2017 17,253
PP_PREV_DSD Aggregated Age/sex: 15+ Male 2017 6,436
PP_PREV_DSD Aggregated Age/sex: <15 Female 2017 5,469
PP_PREV_DSD Aggregated Age/sex: <15 Male 2017 5,047
PP_PREV_DSD Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 34,205
PP_PREV_DSD Total number of people in the target population 2017 112,986
PrEP_NEW_DSD Female 15-19 2017 335
PrEP_NEW_DSD Female 20-24 2017 153
PrEP_NEW_DSD Female 25-49 2017 91
PrEP_NEW_DSD Female 50+ 2017 9
PrEP_NEW_DSD Male 15-19 2017 248
PrEP_NEW_DSD Male 20-24 2017 66
PrEP_NEW_DSD Male 25-49 2017 91
PrEP_NEW_DSD Male 50+ 2017 7
PrEP_NEW_DSD Number of individuals who have received antiretroviral preexposure 2017 1,000
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 118
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 249
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 372
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 372
TB_ART_TA Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 8
TB_ART_TA Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 16
TB_ART_TA The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 24
TB_ART_TA The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 24
TB_SCREENDX_DSD Screen Result: Screened Positive for TB 2017 736
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Female 2017 22,893
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Male 2017 11,792
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Female 2017 1,172
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Male 2017 1,038
TB_SCREENDX_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 36,895
TB_SCREENDX_DSD [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,952
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 292
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 887
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,773
TB_SCREENDX_TA Screen Results: Screened Positive for TB 2017 50
TB_SCREENDX_TA Screened for TB by Age/Sex: 15+ Female 2017 1,579
TB_SCREENDX_TA Screened for TB by Age/Sex: 15+ Male 2017 815
TB_SCREENDX_TA Screened for TB by Age/Sex: <15 Female 2017 91
TB_SCREENDX_TA Screened for TB by Age/Sex: <15 Male 2017 79
TB_SCREENDX_TA The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 2,564
TB_SCREENDX_TA [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 206
TB_SCREENDX_TA [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 21
TB_SCREENDX_TA [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 61
TB_SCREENDX_TA [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 124
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 297
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 21
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 543
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 25
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 886
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2017 886
TB_STAT_TA Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 23
TB_STAT_TA Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 36
TB_STAT_TA Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 59
TB_STAT_TA Total number of registered new and relapsed TB cases, during the reporting period 2017 59
TX_CURR_DSD Age/Sex: 10-14 Female 2017 852
TX_CURR_DSD Age/Sex: 10-14 Male 2017 737
TX_CURR_DSD Age/Sex: 15-19 Female 2017 1,146
TX_CURR_DSD Age/Sex: 15-19 Male 2017 353
TX_CURR_DSD Age/Sex: 20-24 Female 2017 5,265
TX_CURR_DSD Age/Sex: 20-24 Male 2017 2,360
TX_CURR_DSD Age/Sex: 25-49 Female 2017 15,336
TX_CURR_DSD Age/Sex: 25-49 Male 2017 8,488
TX_CURR_DSD Age/Sex: 50+ Female 2017 1,146
TX_CURR_DSD Age/Sex: 50+ Male 2017 591
TX_CURR_DSD Age/Sex: <1 2017 83
TX_CURR_DSD Age/Sex: <1-9 2017 538
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2017 22,893
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2017 11,792
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2017 1,172
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2017 1,038
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2017 36,895
TX_CURR_DSD Sum of age/sex disaggregates 2017 1,499
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2017 34,685
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2017 2,210
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2017 36,895
TX_CURR_TA Age/Sex: 1-9 2017 45
TX_CURR_TA Age/Sex: 10-14 Female 2017 66
TX_CURR_TA Age/Sex: 10-14 Male 2017 56
TX_CURR_TA Age/Sex: 15-19 Female 2017 78
TX_CURR_TA Age/Sex: 15-19 Male 2017 25
TX_CURR_TA Age/Sex: 20-24 Female 2017 363
TX_CURR_TA Age/Sex: 20-24 Male 2017 163
TX_CURR_TA Age/Sex: 25-49 Female 2017 1,060
TX_CURR_TA Age/Sex: 25-49 Male 2017 585
TX_CURR_TA Age/Sex: 50+ Female 2017 78
TX_CURR_TA Age/Sex: 50+ Male 2017 42
TX_CURR_TA Age/Sex: <1 2017 3
TX_CURR_TA Aggregated Age/Sex: 15+ Female 2017 1,579
TX_CURR_TA Aggregated Age/Sex: 15+ Male 2017 815
TX_CURR_TA Aggregated Age/Sex: <15 Female 2017 91
TX_CURR_TA Aggregated Age/Sex: <15 Male 2017 79
TX_CURR_TA Number of adults and children receiving antiretroviral therapy (ART) 2017 2,564
TX_CURR_TA Sum of Age/Sex disaggregations 2017 103
TX_CURR_TA Sum of Aggregated Age/Sex 15+ 2017 2,394
TX_CURR_TA Sum of Aggregated Age/Sex <15 2017 170
TX_CURR_TA Sum of Aggregated Age/Sex disaggregates 2017 2,564
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2017 6,981
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2017 3,593
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2017 231
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2017 195
TX_NEW_DSD By Age/Sex: 1-9 2017 105
TX_NEW_DSD By Age/Sex: 10-14 Female 2017 175
TX_NEW_DSD By Age/Sex: 10-14 Male 2017 137
TX_NEW_DSD By Age/Sex: 15-19 Female 2017 349
TX_NEW_DSD By Age/Sex: 15-19 Male 2017 104
TX_NEW_DSD By Age/Sex: 20-24 Female 2017 1,607
TX_NEW_DSD By Age/Sex: 20-24 Male 2017 721
TX_NEW_DSD By Age/Sex: 25-49 Female 2017 4,678
TX_NEW_DSD By Age/Sex: 25-49 Male 2017 2,587
TX_NEW_DSD By Age/Sex: 50+ Female 2017 347
TX_NEW_DSD By Age/Sex: 50+ Male 2017 181
TX_NEW_DSD By Age/Sex: <1 2017 9
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 11,000
TX_NEW_DSD Sum of Age/Sex disaggregates 2017 10,886
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2017 11,000
TX_NEW_TA Aggregated Grouping by Age/Sex: 15+ Female 2017 553
TX_NEW_TA Aggregated Grouping by Age/Sex: 15+ Male 2017 288
TX_NEW_TA Aggregated Grouping by Age/Sex: <15 Female 2017 24
TX_NEW_TA Aggregated Grouping by Age/Sex: <15 Male 2017 18
TX_NEW_TA By Age/Sex: 1-9 2017 9
TX_NEW_TA By Age/Sex: 10-14 Female 2017 21
TX_NEW_TA By Age/Sex: 10-14 Male 2017 12
TX_NEW_TA By Age/Sex: 15-19 Female 2017 27
TX_NEW_TA By Age/Sex: 15-19 Male 2017 8
TX_NEW_TA By Age/Sex: 20-24 Female 2017 127
TX_NEW_TA By Age/Sex: 20-24 Male 2017 57
TX_NEW_TA By Age/Sex: 25-49 Female 2017 370
TX_NEW_TA By Age/Sex: 25-49 Male 2017 208
TX_NEW_TA By Age/Sex: 50+ Female 2017 29
TX_NEW_TA By Age/Sex: 50+ Male 2017 15
TX_NEW_TA Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 883
TX_NEW_TA Sum of Age/Sex disaggregates 2017 874
TX_NEW_TA Sum of Aggregated Age/Sex disaggregates 2017 883
TX_PVLS_DSD Denominator Aggregated Age/Sex: 15+ Female 2017 18,310
TX_PVLS_DSD Denominator Aggregated Age/Sex: 15+ Male 2017 9,435
TX_PVLS_DSD Denominator Aggregated Age/Sex: <15 Female 2017 938
TX_PVLS_DSD Denominator Aggregated Age/Sex: <15 Male 2017 831
TX_PVLS_DSD Denominator: Indication: Routine 2017 29,514
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 29,514
TX_PVLS_DSD Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 26,563
TX_PVLS_DSD Numerator Aggregated Age/Sex: 15+ Female 2017 16,476
TX_PVLS_DSD Numerator Aggregated Age/Sex: 15+ Male 2017 8,496
TX_PVLS_DSD Numerator Aggregated Age/Sex: <15 Female 2017 843
TX_PVLS_DSD Numerator Aggregated Age/Sex: <15 Male 2017 748
TX_PVLS_DSD Numerator: Indication: Routine 2017 26,563
TX_PVLS_TA Denominator Aggregated Age/Sex: 15+ Female 2017 1,263
TX_PVLS_TA Denominator Aggregated Age/Sex: 15+ Male 2017 651
TX_PVLS_TA Denominator Aggregated Age/Sex: <15 Female 2017 73
TX_PVLS_TA Denominator Aggregated Age/Sex: <15 Male 2017 63
TX_PVLS_TA Denominator: Indication: Routine 2017 2,050
TX_PVLS_TA Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 2,050
TX_PVLS_TA Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,845
TX_PVLS_TA Numerator Aggregated Age/Sex: 15+ Female 2017 1,135
TX_PVLS_TA Numerator Aggregated Age/Sex: 15+ Male 2017 589
TX_PVLS_TA Numerator Aggregated Age/Sex: <15 Female 2017 65
TX_PVLS_TA Numerator Aggregated Age/Sex: <15 Male 2017 56
TX_PVLS_TA Numerator: Indication: Routine 2017 1,845
TX_RET_DSD Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 103
TX_RET_DSD Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 96
TX_RET_DSD Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 155
TX_RET_DSD Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 141
TX_RET_DSD Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 172
TX_RET_DSD Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 157
TX_RET_DSD Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 170
TX_RET_DSD Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 148
TX_RET_DSD Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 211
TX_RET_DSD Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 188
TX_RET_DSD Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 757
TX_RET_DSD Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 672
TX_RET_DSD Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,389
TX_RET_DSD Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 35
TX_RET_DSD Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,203
TX_RET_DSD Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,953
TX_RET_DSD Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,015
TX_RET_DSD Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,453
TX_RET_DSD Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 162
TX_RET_DSD Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 149
TX_RET_DSD Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 339
TX_RET_DSD Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,511
TX_RET_DSD Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11
TX_RET_DSD Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,292
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,922
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6,954
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6,187
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 202
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 185
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 240
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 220
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 9,514
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 10,688
TX_RET_TA Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3
TX_RET_TA Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET_TA Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_TA Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11
TX_RET_TA Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 13
TX_RET_TA Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 12
TX_RET_TA Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_TA Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11
TX_RET_TA Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 13
TX_RET_TA Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 12
TX_RET_TA Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 48
TX_RET_TA Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 41
TX_RET_TA Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 89
TX_RET_TA Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET_TA Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 142
TX_RET_TA Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 126
TX_RET_TA Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 318
TX_RET_TA Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 282
TX_RET_TA Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9
TX_RET_TA Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET_TA Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_TA Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 98
TX_RET_TA Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 211
TX_RET_TA Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 188
TX_RET_TA Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 442
TX_RET_TA Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 393
TX_RET_TA Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_TA Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 12
TX_RET_TA Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 15
TX_RET_TA Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET_TA Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 607
TX_RET_TA Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 680
VMMC_CIRC_DSD By Age: 10-14 2017 23,685
VMMC_CIRC_DSD By Age: 15-19 2017 17,611
VMMC_CIRC_DSD By Age: 20-24 2017 8,505
VMMC_CIRC_DSD By Age: 25-29 2017 4,854
VMMC_CIRC_DSD By Age: 30-49 2017 4,854
VMMC_CIRC_DSD By Age: 50+ 2017 1,215
VMMC_CIRC_DSD By circumcision technique: Device-based VMMC 2017 860
VMMC_CIRC_DSD By circumcision technique: Surgical VMMC 2017 59,864
VMMC_CIRC_DSD Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 60,724
VMMC_CIRC_DSD Sum of age disaggregates (FY15-Current) 2017 60,724
VMMC_CIRC_DSD Sum of age disaggregates (Prior to FY15) 2017 51,016
Cross Cutting Budget Categories and Known Amounts Total: $3,492,000
Human Resources for Health $100,000
Food and Nutrition: Policy, Tools, and Service Delivery $2,000
Food and Nutrition: Commodities $10,000
Economic Strengthening $8,000
Construction $2,000,000
Motor Vehicles: Purchased $210,000
Key Populations: MSM and TG $12,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Training of health workers and community outreach workers
Key Populations: FSW $30,000
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Monitoring and evaluation of SW programs
Collection and use of strategic information on SWs and clients
Training of health workers and community outreach workers
Renovation $1,000,000
Gender: Gender Based Violence (GBV) $120,000
GBV Prevention
Capacity building
Monitoring and Evaluation